Surprisedly, a new study has shown that the FMNL2 gene participates in the development of cerebrovascular disease and AD, suggesting that changes in FMNL2 activity caused by cerebrovascular disease prevent effective clearance of toxic proteins from the brain, ultimately leading to AD [357]. Here, FMNL2 is linked to cerebrovascular disorder.